Pirtobrutinib is a type of inhibitor that targets BTK signaling for treating mantle cell lymphoma and CLL. It’s available in two sizes: there’s a 50 mg tablet and a 100 mg one.
You’re supposed to take 200 mg of it every day. The stuff comes in bottles with 60 tablets in each.
